Foley & Lardner LLP advised Bluestone Equity Partners on the deal. Bluestone Equity Partners (Bluestone), the global sports, media, and entertainment (SME) private equity firm, announced...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments, acted as lead investor in the $26...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised Century Equity Partners on the deal. Century Equity Partners and its portfolio company Flores & Associates LLC (Flores), a leading provider...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments with over $190 billion of assets...
You must be a Standard 1 Year member to access this content.
Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts. CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP advised FAT Brands on the deal. FAT (Fresh. Authentic. Tasty.) Brands Inc. (“FAT Brands” or the “Company”) announced its acquisition of Fazoli’s for...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised Aspirus, Inc. on the deal. Aspirus, Inc., a non-profit, community-directed health system based in Wausau, Wisconsin, announced its assumption of ownership from Ascension...
You must be a Standard 1 Year member to access this content.
